OVID logo

Ovid Therapeutics (OVID)

Profile

Full Name

Ovid Therapeutics Inc.

Ticker Symbol

OVID

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 5, 2017

Indexes

Not included

Website

http://www.ovidrx.com

Employees

23

Key Details

Price

$0.29(+2.50%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$566.00K(+44.39% YoY)

Annual EPS

-$0.37(+49.32% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.29
OVID price is $0.29

30-Day Relative Volume

0.88
OVID 30-day relative volume is 0.88

Price Performance

Price Most recent change

+2.5%
OVID price was up +2.5% on Apr 14, 2025

Price YTD change

-69.27%
OVID price is down -69.27% since January 1st

Price 1-year change

-91.03%
OVID price is down -91.03% year-on-year

Price 3-year change

-91.06%
OVID price is down -91.06% over the past 3 years

Price Range

Price All-time high

$15.93
OVID price is currently -98.20% below its historical high of $15.93

Price 3-year low

$0.24
OVID price is currently +18.11% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$20.40M
OVID market capitalization is $20.40 million

Market cap 3-year change

-90.98%
OVID market capitalization is down -90.98% over the past 3 years

Market cap All-time high

$470.36M
OVID market capitalization is currently -95.66% below its historical high of $470.36 million

Market cap sector rank

27.63%
OVID market capitalization is higher than 27.63% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.37%
OVID shares outstanding is up +0.37% year-on-year

Shares Outstanding 3-Year Change

+0.93%
OVID shares outstanding is up +0.93% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.30
OVID beta is 1.30

200-day SMA

$0.90
OVID price is currently -68.06% below its 200-day simple moving average

50-day SMA

$0.48
OVID price is currently -40.21% below its 50-day simple moving average

RSI

34.25
OVID 14-day relative strength index is 34.25

Volume

0.88
OVID 30-day relative volume is 0.88

ATR

$0.04
OVID average true range is $0.04

10-day Historical Volatility

136.32%
OVID 10-day historical volatility is 136.32%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$566.00K
OVID annual revenue is $566.00 thousand

Revenue Analysts estimate

$210.86K
OVID annual revenue is currently +168.42% higher than the consensus analysts' forecast

Revenue 1-year change

+44.39%
OVID annual revenue is up +44.39% year-on-year

Revenue Sector rank

10.3%
OVID annual revenue is higher than 10.3% of companies in Healthcare sector

EPS

EPS

-$0.37
OVID annual earnings per share is -$0.37

EPS Analysts estimate

-$0.56
OVID annual earnings per share is currently -33.93% lower than the consensus analysts' forecast

EPS 1-year change

+49.32%
OVID annual earnings per share is up +49.32% year-on-year

EPS Sector rank

72.21%
OVID annual earnings per share is higher than 72.21% of companies in Healthcare sector

Profit

Gross profit

-
OVID annual gross profit value is unknown

Gross margin

-
OVID annual gross profit margin value is unknown

Operating profit

-$61.88M
OVID annual operating income is -$61.88 million

Operating margin

-10.93K%
OVID annual operating profit margin is -10.93 thousand%

Net income

-$26.43M
OVID annual net profit is -$26.43 million

Net margin

-4670.14%
OVID annual net profit margin is -4670.14%

Expenses

Total expenses

$62.45M
OVID annual total expenses is $62.45 million

Operating expenses

$62.45M
OVID annual total operating expenses is $62.45 million

Cost of goods sold

-
OVID annual cost of goods sold value is unknown

Selling, general & administrative expenses

$25.68M
OVID annual SGA is $25.68 million

Depreciation and amortization

$613.00K
OVID annual depreciation & amortization is $613.00 thousand

Interest expense

-
OVID annual interest expense value is unknown

Income tax

$0.00
OVID annual income tax is $0.00

EBIT & EBITDA

EBIT

-$61.88M
OVID annual earnings before interest & taxes is -$61.88 million

EBITDA

-$61.27M
OVID annual EBITDA is -$61.27 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$92.17M
OVID annual total assets is $92.17 million

Non current assets

$36.23M
OVID annual long term assets is $36.23 million

Current assets

$55.94M
OVID annual total current assets is $55.94 million

Cash and cash equivalents

$26.30M
OVID annual cash & cash equivalents is $26.30 million

Accounts receivable

-
OVID annual accounts receivable value is unknown

Inventory

-
OVID annual inventory value is unknown

Liabilities

Total liabilities

$23.94M
OVID annual total liabilities is $23.94 million

Long term liabilities

$13.42M
OVID annual total long term liabilities is $13.42 million

Current liabilities

$10.52M
OVID annual total current liabilities is $10.52 million

Accounts payable

$3.19M
OVID annual accounts payable is $3.19 million

Debt

Total debt

$14.76M
OVID annual total debt is $14.76 million

Total debt 1-year change

-7.79%
OVID annual total debt is down -7.79% year-on-year

Long term debt

$13.42M
OVID annual long term debt is $13.42 million

Short term debt

$1.34M
OVID annual short term debt is $1.34 million

Equity & Capital

Shareholders equity

$68.23M
OVID annual stockholders equity is $68.23 million

Book value

$68.23M
OVID annual book value is $68.23 million

Retained earnings

-$304.30M
OVID annual retained earnings is -$304.30 million

Working capital

$45.42M
OVID annual working capital is $45.42 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$55.96M
OVID annual cash flow from operations is -$55.96 million

Cash from operations 1-year change

-22.23%
OVID annual cash flow from operations is down -22.23% year-on-year

Cash from investing

$54.59M
OVID annual cash flow from investing activities is $54.59 million

Cash from investing 1-year change

+2215.23%
OVID annual cash flow from investing activities is up +2215.23% year-on-year

Cash from financing

$622.00K
OVID annual cash flow from financing activities is $622.00 thousand

Cash from financing 1-year change

-97.96%
OVID annual cash flow from financing activities is down -97.96% year-on-year

CAPEX

CAPEX

$161.00K
OVID annual capital expenditures is $161.00 thousand

CAPEX 1-year change

+17.52%
OVID annual capital expenditures is up +17.52% year-on-year

Free Cash Flow

Free cash flow

-$56.12M
OVID annual free cash flow is -$56.12 million

Free cash flow 1-year change

-22.21%
OVID annual free cash flow is down -22.21% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
OVID annual gross profit margin value is unknown

Operating margin

-10.93K%
OVID annual operating profit margin is -10.93 thousand%

Net margin

-4670.14%
OVID annual net profit margin is -4670.14%

ROA & ROE

ROA

-22.38%
OVID annual return on assets is -22.38%

ROE

-33.88%
OVID annual return on equity is -33.88%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
OVID price to earnings ratio value is unknown

PE ratio Sector rank

-
OVID price to earnings ratio is unknown

PB Ratio

PB ratio

0.30
OVID price to book ratio is 0.30

PB ratio Sector rank

23.46%
OVID price to book ratio is higher than 23.46% of companies in Healthcare sector

PS Ratio

PS ratio

36.04
OVID price to sales ratio is 36.04

PS ratio Sector rank

90.26%
OVID price to sales ratio is higher than 90.26% of companies in Healthcare sector

Enterprise value

Enterprise value

$8.85M
OVID enterprise value is $8.85 million

Enterprise value Sector rank

23.64%
OVID enterprise value is higher than 23.64% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.14
OVID EV/EBITDA is -0.14

EV/EBITDA Sector rank

59.83%
OVID EV/EBITDA is higher than 59.83% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.32
OVID annual current ratio is 5.32

Quick ratio

-
OVID annual quick ratio value is unknown

Leverage

Debt to equity

0.00
OVID annual debt to equity ratio is 0.00

Interest coverage ratio

-
OVID annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
OVID piotroski f-score value is unknown

Altman Z-Score

-5.73
OVID altman z-score is -5.73

Analyst ratings

Recent major analysts updates

Mar 24, 25 BTIG
Buy
Mar 12, 25 Wedbush
Outperform
Jan 29, 25 Oppenheimer
Outperform
Dec 4, 24 HC Wainwright & Co.
Buy
Sep 30, 24 HC Wainwright & Co.
Buy
Aug 19, 24 HC Wainwright & Co.
Buy
Jul 26, 24 HC Wainwright & Co.
Buy
Jul 2, 24 HC Wainwright & Co.
Buy
Jun 18, 24 HC Wainwright & Co.
Buy
Jun 18, 24 Citigroup
Neutral

Institutional Ownership

Similar stocks

CDIO logo
Cardio Diagnostics Holdings (CDIO)
XAIR logo
Beyond Air (XAIR)
CYTH logo
Cyclo Therapeutics (CYTH)
IPA logo
ImmunoPrecise Antibodies (IPA)
ENLV logo
Enlivex Therapeutics (ENLV)
RVP logo
Retractable Technologies (RVP)
PULM logo
Pulmatrix (PULM)
NEPH logo
Nephros (NEPH)
COEP logo
Coeptis Therapeutics (COEP)
  • What is the ticker symbol for Ovid Therapeutics?
  • Does Ovid Therapeutics pay dividends?
  • What sector is Ovid Therapeutics in?
  • What industry is Ovid Therapeutics in?
  • What country is Ovid Therapeutics based in?
  • When did Ovid Therapeutics go public?
  • Is Ovid Therapeutics in the S&P 500?
  • Is Ovid Therapeutics in the NASDAQ 100?
  • Is Ovid Therapeutics in the Dow Jones?
  • When was Ovid Therapeutics's last earnings report?
  • When does Ovid Therapeutics report earnings?
  • Should I buy Ovid Therapeutics stock now?

What is the ticker symbol for Ovid Therapeutics?

The ticker symbol for Ovid Therapeutics is NASDAQ:OVID

Does Ovid Therapeutics pay dividends?

No, Ovid Therapeutics does not pay dividends

What sector is Ovid Therapeutics in?

Ovid Therapeutics is in the Healthcare sector

What industry is Ovid Therapeutics in?

Ovid Therapeutics is in the Biotechnology industry

What country is Ovid Therapeutics based in?

Ovid Therapeutics is headquartered in United States

When did Ovid Therapeutics go public?

Ovid Therapeutics's initial public offering (IPO) was on May 5, 2017

Is Ovid Therapeutics in the S&P 500?

No, Ovid Therapeutics is not included in the S&P 500 index

Is Ovid Therapeutics in the NASDAQ 100?

No, Ovid Therapeutics is not included in the NASDAQ 100 index

Is Ovid Therapeutics in the Dow Jones?

No, Ovid Therapeutics is not included in the Dow Jones index

When was Ovid Therapeutics's last earnings report?

Ovid Therapeutics's most recent earnings report was on Mar 11, 2025

When does Ovid Therapeutics report earnings?

The next expected earnings date for Ovid Therapeutics is May 14, 2025

Should I buy Ovid Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page